Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Judge upholds $467m Masimo win over Philips
Masimo this week won another round in its $467 million patent infringement war with Royal Philips over pulse oximetry technology.
A federal judge in Delaware upheld last year’s $467 million judgment against Philips, denying the Dutch healthcare giant’s claim that Masimo lawyers withheld information from the U.S. Patent & Trademark Office. Read more
2. Valeritas touts real-world V-Go data
Valeritas touted real-world data from 3 separate studies of its V-Go insulin delivery system showcasing the device’s utility and effectiveness.
V-Go is a disposable, wearable insulin delivery device designed to deliver a preset dosage continually over 24 hours and on-demand doses during meals. Read more
1. Analyst: ConMed ripe for M&A spree
ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter.
Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in a note to investors yesterday that ConMed’s “turnaround and 2-3 yr sales/EPS growth prospects are underappreciated.” Read more
